New hope for toddlers with aggressive brain cancer: experimental spinal-fluid chemo

NCT ID NCT06942039

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This early-phase study tests whether adding chemotherapy directly into the spinal fluid (intrathecal topotecan) followed by maintenance pills is feasible for children under 6 with high-risk embryonal brain tumors. About 15 children will receive this treatment after standard high-dose chemo. The goal is to see if the approach is safe enough to study further, not to cure the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATYPICAL TERATOID/RHABDOID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alberta Children's Hospital

    RECRUITING

    Calgary, Alberta, Canada

  • BC Children's Hospital

    RECRUITING

    Vancouver, British Columbia, Canada

  • CHU Sainte-Justine

    RECRUITING

    Montreal, Quebec, Canada

  • CHU de Québec-Université Laval

    RECRUITING

    Québec, Quebec, Canada

  • CancerCare Manitoba (CCMB)

    RECRUITING

    Winnipeg, Manitoba, Canada

  • Centre hospitalier universitaire de Sherbrooke (CHUS)

    RECRUITING

    Sherbrooke, Quebec, Canada

  • IWK Health Centre

    NOT_YET_RECRUITING

    Halifax, Nova Scotia, Canada

  • London Health Sciences Centre

    RECRUITING

    London, Ontario, Canada

  • McMaster Children's Hospital

    RECRUITING

    Hamilton, Ontario, Canada

  • Montreal Children's Hospital (McGill)

    NOT_YET_RECRUITING

    Montreal, Quebec, Canada

  • Stollery Children's Hospital

    RECRUITING

    Edmonton, Canada

  • The Hospital for Sick Children

    RECRUITING

    Toronto, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.